Top FDA official takes over vaccine office as agency weighs COVID-19 shots for children
Difficult vaccine decisions lie ahead. The agency could soon determine how to handle boosters for recipients of Moderna and Johnson & Johnson’s shots.
Nursing union says hospitals aren’t following OSHA standard amid delta
Industry groups opposed the rules laying out masking, social distancing, testing and exposure notification requirements for hospitals and nursing homes. Implementation was required in July.
Cleveland Clinic forecasts latest COVID-19 surge will soon peak as nation sees declining hospitalizations
Lower volumes are a welcome sign for health systems that have been overwhelmed by patient volumes and forced to delay nonemergency procedures. The downward trend signals a return to normal for operators.
Delta pressure on US hospitals dragged August operations, Kaufman Hall finds
“The August data show we are not out of the woods yet, and hospitals face additional uncertainties as we move into the fall and winter,” Erik Swanson, senior vice president of data and analytics at Kaufman Hall, said.
Beaumont, Spectrum deal delayed by FTC backlog
The two Michigan health systems expected the union to close this fall. But now it will take longer than originally anticipated as the Federal Trade Commission is experiencing a surge in merger filings.
Broadband investments can improve health, as long as insurers don’t roll back telehealth coverage
Jason Resendez of Consumers for Quality Care argues it’s time for insurers, policymakers and health systems to embrace telehealth as an integral part of the future of healthcare.
Healthcare 2025: Health plans look ahead to emerging business opportunities
Eager to learn how health plans view their role and other stakeholders in the overall healthcare ecosystem today?
Cigna expands purview of global CIO
Noelle Eder, who first joined the company in August 2020, will add data and analytics to her role.
CDC recommends Pfizer booster shots for many, overruling advisers on broad use
Though an agency panel voted against advising a third Pfizer vaccine dose for younger people in high-risk jobs like nursing or teaching, it was overriden by CDC Director Rochelle Walensky.
6 drug companies could face steep fines for violating 340B law
The ongoing refusal of Eli Lilly, AstraZeneca, Novartis, Novo Nordisk, Sanofi and United Therapeutics to offer discounts to safety-net providers through community pharmacy partnerships has been referred to OIG for enforcement.